<p>Characteristics of the 33 patients included in the prostate cancer validation cohort are shown. Age and baseline PSA were abstracted from the time of diagnosis. Gleason score is as recorded by the clinical genitourinary pathologist. Clinical staging of the primary tumor is per the 7<sup>th</sup> edition of the American Joint Committee on Cancer (AJCC) staging manual.</p
<p>Patient demographics and clinical characteristics among 300 men who underwent an MRI and 4Kscore ...
<p>PSA, prostate-specific antigen; PSAD, prostate-specific antigen density; DRE, digital rectal exam...
objectives: This population-based study provides comparisons of prostate cancer characteristics at d...
<p>*Median age of the patients with benign prostatic hyperplasia (n = 42) were 71 years (range, 48 t...
<p>Baseline characteristics of 87 prostate cancer and 24 BPH patients included in the study.</p
*<p>T-test for age distributions between the cases and controls; two-sided χ<sup>2</sup> test for ot...
<p><sup>a</sup>Treatment is defined as the treatment within 4 months after diagnosis of prostate can...
<p>*Adjustments: 1.Age, 2.smoking status, 3.prior cancer diagnosis, 4.place of residency, 5.use of o...
To investigate changes of the stage, age of onset, and prostate specific antigen (PSA) level of pros...
Background. We have previously described an algorithm APhiGT (Age, Prostate Health index, Gleason sc...
<p>* Adjustments: 1.Age, 2.smoking status, 3.prior cancer diagnosis, 4.place of residency, 5.use of ...
*<p>Pre-intervention PSA was available from 88 of the 129 patients who underwent RP and from 10 of t...
<p>* Adjustments: 1.Age, 2.smoking status, 3.prior cancer diagnosis, 4.place of residency, 5.use of ...
<p>Clinical characteristics of total cohort and patients and pN1 prostate cancer after radical prost...
<p>The bolded segment of the ProMedDx numbers are the subjects that did not fall in our age-match ca...
<p>Patient demographics and clinical characteristics among 300 men who underwent an MRI and 4Kscore ...
<p>PSA, prostate-specific antigen; PSAD, prostate-specific antigen density; DRE, digital rectal exam...
objectives: This population-based study provides comparisons of prostate cancer characteristics at d...
<p>*Median age of the patients with benign prostatic hyperplasia (n = 42) were 71 years (range, 48 t...
<p>Baseline characteristics of 87 prostate cancer and 24 BPH patients included in the study.</p
*<p>T-test for age distributions between the cases and controls; two-sided χ<sup>2</sup> test for ot...
<p><sup>a</sup>Treatment is defined as the treatment within 4 months after diagnosis of prostate can...
<p>*Adjustments: 1.Age, 2.smoking status, 3.prior cancer diagnosis, 4.place of residency, 5.use of o...
To investigate changes of the stage, age of onset, and prostate specific antigen (PSA) level of pros...
Background. We have previously described an algorithm APhiGT (Age, Prostate Health index, Gleason sc...
<p>* Adjustments: 1.Age, 2.smoking status, 3.prior cancer diagnosis, 4.place of residency, 5.use of ...
*<p>Pre-intervention PSA was available from 88 of the 129 patients who underwent RP and from 10 of t...
<p>* Adjustments: 1.Age, 2.smoking status, 3.prior cancer diagnosis, 4.place of residency, 5.use of ...
<p>Clinical characteristics of total cohort and patients and pN1 prostate cancer after radical prost...
<p>The bolded segment of the ProMedDx numbers are the subjects that did not fall in our age-match ca...
<p>Patient demographics and clinical characteristics among 300 men who underwent an MRI and 4Kscore ...
<p>PSA, prostate-specific antigen; PSAD, prostate-specific antigen density; DRE, digital rectal exam...
objectives: This population-based study provides comparisons of prostate cancer characteristics at d...